Clinical Research Directory
Browse clinical research sites, groups, and studies.
Molecular Analysis and Treatment Options of Thymic Malignancies
Sponsor: Shanghai Chest Hospital
Summary
Thymic malignancies are the most common tumors of the anterior mediastinum, though surgery and radiation often effectively treat thymic carcinomas, a minority continue to progress and eventually lead to death. Therefore, there is an unmet need for more effective therapies for thymic malignancies. Considering the role of molecular alterations has yet to be defined in the treatment of thymoma and thymic malignancies, there is an urgent recognition that molecular alterations in the thymic malignancies are important to predict response and survival for novel targeted therapies. In summary, identification of genetic alterations in thymic malignancies is increasingly essential to perform molecular diagnostics and individualized treatments. This project aims to create a registry of patients with thymic malignancies to further the characterization of molecular alterations and develop (novel) treatments based on the detection.
Official title: Molecular Landscape Analysis and Treatment Options for Thymic Epithelial Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2016-01-01
Completion Date
2026-12-31
Last Updated
2025-05-22
Healthy Volunteers
No
Interventions
Chemotherapy
different treatments based on the molecular analysis
Locations (1)
Xiaomin Niu
Shanghai, Shanghai Municipality, China